Talbot Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-99,996
| Closed | -$5.66M | – | 64 |
|
|
2024
Q4 | $5.66M | Buy |
99,996
+5,813
| +6% | +$329K | 0.67% | 45 |
|
|
2024
Q3 | $4.87M | Buy |
94,183
+5,950
| +7% | +$308K | 0.59% | 46 |
|
|
2024
Q2 | $3.66M | Buy |
88,233
+9,964
| +13% | +$414K | 0.47% | 44 |
|
|
2024
Q1 | $4.24M | Buy |
78,269
+5,345
| +7% | +$290K | 0.57% | 45 |
|
|
2023
Q4 | $3.74M | Sell |
72,924
-5,524
| -7% | -$283K | 0.56% | 44 |
|
|
2023
Q3 | $4.55M | Buy |
78,448
+3,763
| +5% | +$218K | 0.79% | 44 |
|
|
2023
Q2 | $4.78M | Buy |
74,685
+8,078
| +12% | +$517K | 0.81% | 44 |
|
|
2023
Q1 | $4.62M | Buy |
66,607
+4,308
| +7% | +$299K | 0.86% | 43 |
|
|
2022
Q4 | $4.48M | Buy |
+62,299
| New | +$4.48M | 0.92% | 40 |
|